Ampio Pharmaceuticals (AMPE) Trading Up 21.5%
Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) was up 21.5% during mid-day trading on Wednesday . The stock traded as high as $3.55 and last traded at $3.33. Approximately 2,644,700 shares changed hands during trading, an increase of 315% from the average daily volume of 636,767 shares. The stock had previously closed at $2.74.
Separately, ValuEngine upgraded shares of Ampio Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 11th.
The stock has a market capitalization of $276.69, a PE ratio of -20.95 and a beta of 0.58.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.